Lately , there's rising scrutiny on the pharmaceutical sector in this country. While international giants historically held significant influence, a transition appears to be occurring. Quite a few domestic firms have experienced considerable growth , disrupting the established landscape. Concerns are now being asked about whether this indicates a

The growing power of a few dominant medication corporations is sparking grave worries globally. This pattern towards domination often leads to escalated drug charges, limited development, and difficulties in receiving critical medications for patients throughout the world. Experts believe that stronger scrutiny is necessary to resolve these problem

India's pharmaceutical landscape presents a complex picture, largely shaped by the substantial influence of a few dominant players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of sector concentration that warrants scrutiny. These incumbent companies, including names like Su